Related Experiment Video
Updated: May 5, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
131I therapy for benign thyroid disease: flexible single-time-point dosimetry using population-based model selection
Deni Hardiansyah1, Ade Riana1,2, Heribert Hänscheid3
1Medical Physics and Biophysics, Physics Department, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Depok, Indonesia.
Purpose:
This study aimed to evaluate the accuracy of time-integrated activity (TIA) estimation using single-time-point (STP) data combined with nonlinear mixed-effects modelling (NLMEM) and population-based model selection (PBMS) in 73 patients with benign thyroid disease.
Methods:
Biokinetic data of 131I were collected from 73 patients with benign thyroid conditions, including Graves' disease, toxic nodular goitre, and non-toxic goitre. Uptake measurements were taken at 2, 6, 24, 48 (73 patients), 96 h (53 patients) or 120 h (20 patients) after administration. The best sum-of-exponentials function (SOEF) with four adjustable parameters, identified in our recent study (Hardiansyah et al. EJNMMI Phys, 2025) by PBMS NLMEM, and the SOEF EANM standard operating procedure (SOP) with three adjustable parameters were then employed to conduct a NLMEM-based STP dosimetry at different time points, i.e. s1TIA and s2TIAs, respectively. In addition, STP dosimetry was performed using the EANM SOP approach (Hänscheid et al. EJNMMI, 2013) to calculate TIAs (hTIAs). The accuracy of the computed s1TIAs, s2TIAs and hTIAs was evaluated by calculating the relative deviations (RDs), mean absolute percentage errors (MAPEs), root-mean-square errors (RMSEs), and percentage of absolute RDs of sTIAs and hTIAs exceeding 5% (%RD5) and 10% (%RD10) with the reference TIAs obtained from the four parameters NLMEM fit to all time points data.
Results:
Of the time points included, 120 h after administration was found as the optimal time point for STP dosimetry based on the mean ± SD of RD (RMSE, MAPE, %RD5, %RD10) of s1TIA, s2TIAs, and hTIA of 2% ± 4% (4%,3%,25%,0%), 13% ± 6% (14%,13%,90%,60%) and -3% ± 5% (6%,5%,55%,0%), respectively.
Conclusions:
While s1TIA typically produced better 131I TIA estimates for benign thyroid disease than the hTIA recommended in the EANM SOP, the STP calculation from NLMEM using SOEF EANM SOP s2TIAs was inferior to hTIA. With the best SOEF model, NLMEM provides satisfactory and reasonable STP estimates.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Related Concept Videos
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Dosage Regimens: Designs and Approaches
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Pharmacodynamic Models: Additive and Proportional Drug Effect Model